Tue, June 19, 2018
Mon, June 18, 2018
Fri, June 15, 2018
Thu, June 14, 2018
Wed, June 13, 2018

Yun Zhong Initiated (SRPT) at Strong Buy and Held Target at $120 on, Jun 15th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. buy-and-held-target-at-120-on-jun-15th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Yun Zhong of BTIG, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $120 on, Jun 15th, 2018.

Yun has made no other calls on SRPT in the last 4 months.



There are 7 other peers that have a rating on SRPT. Out of the 7 peers that are also analyzing SRPT, 2 agree with Yun's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Hartaj Singh of "Oppenheimer" Downgraded from Buy to Hold on, Friday, May 4th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $91 on, Friday, May 4th, 2018


These are the ratings of the 5 analyists that currently disagree with Yun


  • Gena Wang of "Barclays" Upgraded from Hold to Buy on, Friday, May 11th, 2018
  • Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $92 on, Friday, May 4th, 2018
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $95 on, Wednesday, March 14th, 2018
  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Increased Target to $92 on, Tuesday, March 13th, 2018
  • Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $92 on, Monday, March 12th, 2018